The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The p53 tumour-suppressor protein controls the expression of a gene encoding the p21 cyclin-dependent protein kinase (CDK) regulator. Levels of p21 protein are increased in senescent cells and p21 overexpression blocks the growth of tumour cells. In normal human cells, but not in many tumour cells, p21 exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen (PCNA). p21 controls CDK activity, thereby affecting cell-cycle control, whereas PCNA functions in both DNA replication and repair. Here we use simian virus 40 DNA replication in vitro to show than p21 directly inhibits PCNA-dependent DNA replication in the absence of a cyclin/CDK. Furthermore, p21 blocks the ability of PCNA to activate DNA polymerase delta, the principal replicative DNA polymerase. This regulation results from a direct interaction between p21 and PCNA. Thus, during p53-mediated suppression of cell proliferation, p21 and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 was reported to block replicative DNA synthesis in vitro as well, doing so when reaching a 100:1 ratio [42,43,44].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [44]
In the citing paper
“suggesting that p21–PCNA interaction prevented rather than promoted cell-cycle arrest, as originally postulated based on its ability to displace replicative DNA polymerases from PCNA [43,44].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [44]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Self-citationp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Self-citationKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Self-citationProliferating cell nuclear antigen is required for DNA excision repair
Shivji, M. K. K., Kenny, M. K., & Wood, R. D. (1992) · Cell · doi:10.1016/0092-8674(92)90416-a · Cited by 798
Cited by
Items 701–800 of 1,000
Harada, K., Furubo, S., Ozaki, S., Hiramatsu, K., Sudo, Y., & Nakanuma, Y. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00075-1 · Cited by 47
Inomata, A., Horii, I., & Suzuki, K. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(02)00204-7 · Cited by 49
Staples, M., Marks, R., & Giles, G. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981005)78:2<144::aid-ijc3>3.0.co;2-z · Cited by 288
Ferulic acid inhibits endothelial cell proliferation through NO down‐regulating ERK1/2 pathway
Hou, Y., Yang, J., Zhao, G.-R., & Yuan, Y. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20281 · Cited by 50
Cell cycle regulation: repair and regeneration in acute renal failure
Price, P. M., Megyesi, J. K., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00087-1 · Cited by 45
Retroviral Delivery of Peptide Modulators of Cellular Functions
Lorens, J. B., Bennett, M. K., Pearsall, D., Throndset, W., Rossi, A. B., Armstrong, R. J., Fox, B., Chan, E., Luo, Y., Masuda, E. S., et al. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0063 · Cited by 48
Senescence-like changes induced by expression of p21Waf1/Cip1 in NIH3T3 cell line
Chen, X., Zhang, W., Gao, Y., Su, X., & Zhai, Z. H. (2002) · Cell Research · doi:10.1038/sj.cr.7290129 · Cited by 53
The role of p21CIP1/WAF1 in growth of epithelial cells exposed to hyperoxia
Rancourt, R. C., Keng, P. C., Helt, C. E., & O’Reilly, M. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.4.l617 · Cited by 53
Watson, A. J. M. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00376.x · Cited by 49
Liu, J., Kuo, S., McHugh, M. M., Beerman, T. A., & Melendy, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1391 · Cited by 49
Direct Interaction of Proliferating Cell Nuclear Antigen with the Small Subunit of DNA Polymerase δ
Lu, X., Tan, C.-K., Zhou, J.-Q., You, M., Carastro, L. M., Downey, K. M., & So, A. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200065200 · Cited by 47
Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics
Appleman, L. J., Tzachanis, D., Grader‐Beck, T., van Puijenbroek, A. A. F. L., & Boussiotis, V. A. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090000180 · Cited by 53
Yang, W., Velcich, A., Mariadason, J. M., Nicholas, C., Corner, G. A., Houston, M. A., Edelmann, W., Kucherlapati, R., Holt, P. R., & Augenlicht, L. H. (2001) · PubMed · Cited by 57
Therapeutic Targeting of DNA Replication Stress in Cancer
Gu, L., Hickey, R. J., & Malkas, L. H. (2023) · Genes · doi:10.3390/genes14071346 · Cited by 54
Chang, W., Yu, Y., Chiang, S., & Tseng, C.-Y. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114507831734 · Cited by 46
Liu, Z., & Huang, H. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.006 · Cited by 48
Kato, K., Kawashiri, S., Yoshizawa, K., Kitahara, H., Okamune, A., Sugiura, S., Noguchi, N., & Yamamoto, E. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01032.x · Cited by 46
Replisome Dynamics and Their Functional Relevance upon DNA Damage through the PCNA Interactome
Srivastava, M., Chen, Z., Zhang, H., Tang, M., Wang, C., Jung, S. Y., & Chen, J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.099 · Cited by 50
The roles of the eukaryotic DNA polymerases in DNA repair synthesis
Budd, M. E., & Campbell, J. L. (1997) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(97)00024-4 · Cited by 47
Cleavage of p21 by Proteinase-3, a Myeloid-specific Serine Protease, Potentiates Cell Proliferation
Witko‐Sarsat, V., Canteloup, S., Durant, S., Desdouets, C., Chabernaud, R., Lemarchand, P., & Descamps‐Latscha, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202789200 · Cited by 48
Wagayama, H., Shiraki, K., Sugimoto, K., Ito, T., Fujikawa, K., Yamanaka, T., Takase, K., & Nakano, T. (2002) · Human Pathology · doi:10.1053/hupa.2002.124724 · Cited by 46
Ishizuka, S., Martin, K., Booth, C., Potten, C. S., de Murcia, G., Bürkle, A., & Kirkwood, T. B. L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg840 · Cited by 48
Stucki, M., Štagljar, I., Jónsson, Z. O., & Hübscher, U. (2000) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(00)65007-9 · Cited by 50
Sutton, M. D., Narumi, I., & Walker, G. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082322099 · Cited by 58
BIOLOGICAL MARKERS IN SUPERFICIAL BLADDER TUMORS AND THEIR PROGNOSTIC SIGNIFICANCE
Zlotta, A. R., & Schulman, C. C. (2000) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70246-9 · Cited by 46
SV40 and cell cycle perturbations in malignant mesothelioma
Testa, J. R., & Giordano, A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0344 · Cited by 56
Nekrasova, T., & Minden, A. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23092 · Cited by 46
Burkovics, P., Dome, L., Juhász, S., Altmannová, V., Šebesta, M., Pačesa, M., Fugger, K., Sørensen, C. S., Lee, M., Haracska, L., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw024 · Cited by 48
Yook, J. I., & Kim, J. H. (1998) · Oral Oncology · doi:10.1016/s1368-8375(97)00091-2 · Cited by 53
Keller, C., & Krude, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003073200 · Cited by 52
S. Lu, J. T. (1999) · Acta Dermato Venereologica · doi:10.1080/000155599750010634 · Cited by 49
Arany, I., Evans, T. Y., & Tyring, S. K. (1998) · Sexually Transmitted Infections · doi:10.1136/sti.74.5.349 · Cited by 45
Biologic factors and response to radiotherapy in carcinoma of the cervix
Mukherjee, G., Freeman, A. H., Moore, R. G., Swamy, K., Devi, K. U., Morris, L. S., Coleman, N., Dilworth, S., Prabhakaran, P. S., & Stanley, M. (2001) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2001.01014.x · Cited by 45
Expression of cyclin E and p27KIP1 in cervical carcinoma
Kim, Y. T., Choi, E. K., Cho, N. H., Ko, J. H., Yang, W. I., Kim, J. W., & Lee, S. H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00345-1 · Cited by 45
Bishay, K., Ory, K., Lebeau, J., Levalois, C., Olivier, M., & Chevillard, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203405 · Cited by 53
Radiation induced G1-block and p53 status in six human cell lines
Zölzer, F., Hillebrandt, S., & Streffer, C. (1995) · Radiotherapy and Oncology · doi:10.1016/0167-8140(95)01618-q · Cited by 48
TGF-β: receptors and cell cycle arrest
Saltis, J. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03721-7 · Cited by 52
Hoffmann, J., Pillaire, M., Lesca, C., Burnouf, D., Fuchs, R. P., Defais, M. J., & Villani, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13766 · Cited by 45
Brush, G. S., Kelly, T. J., & Stillman, B. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)62043-5 · Cited by 45
Self-citationCell Cycle and Senescence Regulation by Podocyte Histone Deacetylase 1 and 2
Rangel, P. X. M., Cross, E., Liu, C., Pedigo, C. E., Tian, X., Gutiérrez-Calabrés, E., Nagata, S., Priyadarshini, A., Lerner, G., Bunda, P., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022050598 · Cited by 47
Cooper, M. L., Choi, J., Karpova, D., Vij, K. R., Ritchey, J., Schroeder, M. A., & DiPersio, J. F. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1502399 · Cited by 44
Zhang, Y., Dong, H., Zhang, J., & Zhang, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6710 · Cited by 48
Becker, J. R., Gallo, D., Leung, W., Croissant, T., Thu, Y. M., Nguyen, H. D., Starr, T. K., Brown, G. W., & Bielinsky, A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky313 · Cited by 46
Mahran, Y. F., Badr, A. M., Aldosari, A., Bin-Zaid, R., & Alotaibi, H. N. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3173745 · Cited by 44
Senescence and p130/Rbl2: a new beginning to the end
Fiorentino, F. P., Symonds, C. E., Macaluso, M., & Giordano, A. (2009) · Cell Research · doi:10.1038/cr.2009.96 · Cited by 48
Rodríguez-Vilarrupla, A., Jaumot, M., Abella, N., Canela-Canela, N., Brun, S., Díaz, C., Estanyol, J. M., Bachs, O., & Agell, N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7364-7374.2005 · Cited by 44
Lin, G.-Y., Chen, Z.-L., Lu, C.-M., Li, Y., Ping, X.-J., & Huang, R. (2000) · World Journal of Gastroenterology · doi:10.3748/wjg.v6.i2.234 · Cited by 44
Knight-Krajewski, S., Welsh, C. F., Liu, Y., Lyons, L. S., Faysal, J. M., Yang, E. S.-H., & Burnstein, K. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207708 · Cited by 46
Rudolph, P., Tronnier, M., Menzel, R., Moller, M., & Parwaresch, R. M. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90019-3 · Cited by 44
Nucleotide Excision Repair: Its Relation to Human Disease
Thompson, L. H. (1998) · DNA Damage and Repair · doi:10.1007/978-1-59259-455-9_18 · Cited by 44
Akama, Y., Yasui, W., Kuniyasu, H., Yokozaki, H., Akagi, M., Tahara, H., Ishikawa, T., & 田原, 榮. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb02106.x · Cited by 46
CYCLOSPORINE INDUCES THE EXPRESSION OF THE CYCLIN INHIBITOR p21
Khanna, A. K., & Hosenpud, J. D. (1999) · Transplantation · doi:10.1097/00007890-199905150-00011 · Cited by 49
A human ribonuclease induces apoptosis associated with p21WAF1/CIP1induction and JNK inactivation
Castro, J., Ribó, M., Navarro, S., Nogués, M. V., Vilanova, M., & Benito, A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-9 · Cited by 43
Levesque, A. A., Fanous, A. A., Poh, A., & Eastman, A. R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2066 · Cited by 44
p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines
Ye, S., Shen, J. K., Choy, E., Cao, Y., Mankin, H. J., Hornicek, F. J., & Duan, Z. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2944-z · Cited by 45
Tofighi, R., Joseph, B., Xia, S., Xu, Q., Hamberger, B., Hökfelt, T. G. M., & Ceccatelli, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712300105 · Cited by 43
Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis
Inoshima, I., Kuwano, K., Hamada, N., Yoshimi, M., Maeyama, T., Hagimoto, N., Nakanishi, Y., & Hara, N. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00209.2003 · Cited by 43
Prostate cancer and inositol hexaphosphate: efficacy and mechanisms.
Singh, R. P., & Agarwal, R. (2005) · PubMed · Cited by 44
Chiou, S., & White, E. (1998) · Virology · doi:10.1006/viro.1998.9077 · Cited by 42
Sustained nuclear localization of p21/WAF-1 upon growth arrest induced by contact inhibition
Ritt, M. G., Mayor, J., Wojcieszyn, J. W., Smith, R., Barton, C. L., & Modiano, J. F. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00507-3 · Cited by 44
Sutton, M. D., Farrow, M. F., Burton, B. M., & Walker, G. C. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.9.2897-2909.2001 · Cited by 50
Lin, S., Chang, J., & Carpenter, E. J. (1995) · Journal of Phycology · doi:10.1111/j.0022-3646.1995.00388.x · Cited by 46
p53 And related proteins in epithelial ovarian cancer
Sengupta, P., McGown, A. T., Bajaj, V., Blackhall, F. H., Swindell, R., Bromley, M., Shanks, J. H., Ward, T. H., BUCKLEY, C. H., Reynolds, K., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00301-4 · Cited by 45
Bickenbach, K. A., Galka, E., & Roggin, K. K. (2009) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2008.12.001 · Cited by 42
DNA-damage tolerance through PCNA ubiquitination and sumoylation
Fan, L., Bi, T., Wang, L., & Xiao, W. (2020) · Biochemical Journal · doi:10.1042/bcj20190579 · Cited by 43
Wang, Z., Zhang, Y., Gu, J. J., Davitt, C. M., Reeves, R., & Magnuson, N. S. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.03.012 · Cited by 44
Zhu, X., Wang, K., Zhang, K., Huang, B., Zhang, J., Zhang, Y., Zhu, L., Zhou, B., & Zhou, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918041 · Cited by 44
Le, N., & Richardson, D. R. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg042 · Cited by 41
García‐España, A., Salazar, E., Sun, T., Wu, X., & Pellicer, À. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2074 · Cited by 44
Lai, M., Lr, L., Cheng, K., & Wing, L. Y. C. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660087 · Cited by 42
Kimura, S., Ueda, T., Hatanaka, M., Takenouchi, M., Hashimoto, J., & Sakaguchi, K. (2000) · Plant Molecular Biology · doi:10.1023/a:1006349511964 · Cited by 45
Nakayama, K., Hara, T., Hibi, M., Hirano, T., & Miyajima, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24766 · Cited by 42
Cistulli, C. A., & Kaufmann, W. K. (1998) · PubMed · Cited by 47
Matsushita, H., Morishita, R., Kida, I., Aoki, M., Hayashi, S.-I., Tomita, N., Yamamoto, K., Moriguchi, A., Noda, A., Kaneda, Y., et al. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.493 · Cited by 42
Prabhu, N. S., Blagosklonny, M. V., Zeng, Y. X., Wu, G. S., Waldman, T. A., & El‐Deiry, W. S. (1996) · PubMed · Cited by 48
Cheng, J. D., Werness, B. A., Babb, J. S., & Meropol, N. J. (1999) · PubMed · Cited by 50
Cheng, X., Cheong, N., Wang, Y., & Iliakis, G. E. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01712-4 · Cited by 43
Underexpression of Cyclin-Dependent Kinase (CDK) Inhibitors in Cervical Carcinoma
Kim, Y. T., Cho, N. H., Park, S. W., & Kim, J. W. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5134 · Cited by 46
Association of p53 with Neurodegeneration in Parkinson’s Disease
Luo, Q., Sun, W., Wang, Y., Li, J., & Li, D.-W. (2022) · Parkinson s Disease · doi:10.1155/2022/6600944 · Cited by 49
Cheung, A., Shen, D., Khoo, U., Wong, L. C., & Ngan, H. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.2.159 · Cited by 41
G1 Cyclins and Control of the Cell Division Cycle in Normal and Transformed Cells
Hamel, P. A., & Hanley-Hyde, J. (1997) · Cancer Investigation · doi:10.3109/07357909709115767 · Cited by 41
Inoue, T., Kato, K., Kato, H., Asanoma, K., Kuboyama, A., Ueoka, Y., Yamaguchi, S., Ohgami, T., & Wake, N. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01166.x · Cited by 42
Warbrick, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209320 · Cited by 40
Karpurapu, M., Wang, D., Singh, N. K., Li, Q., & Rao, G. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800423200 · Cited by 45
Regulation of human DNA polymerase delta in the cellular responses to DNA damage
Lee, M., Zhang, S., Lin, S. H. S., Chea, J., Wang, X., LeRoy, C., Wong, A., Zhang, Z., & Lee, E. Y. C. (2012) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21743 · Cited by 43
PAL31, a Novel Nuclear Protein, Expressed in the Developing Brain
Mutai, H., Toyoshima, Y., Sun, W., Hattori, N., Tanaka, S., & Shiota, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3133 · Cited by 40
Shih, C., Lin, P., Wang, H., Huang, W., & Wang, Y. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00854.x · Cited by 40
Hayashi, Y., Yamagishi, M., Nishimoto, Y., Taguchi, O., Matsukage, A., & Yamaguchi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35080 · Cited by 43
Cell cycle control in growth plate chondrocytes
Luvalle, P. A. (2000) · Frontiers in bioscience · doi:10.2741/luvalle · Cited by 43
Qin, L. F., & Ng, I. O. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00701-7 · Cited by 40
Balajee, A. S., Dianova, I., & Bohr, V. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.22.4476 · Cited by 40
Why are there so many CDK inhibitors?
Xiong, Y. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00012-1 · Cited by 46
Nerve Growth Factor-induced Growth Arrest and Induction of p21 in NIH-3T3 Cells Expressing TrkA
Decker, S. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.30841 · Cited by 44
p21waf1/cip1mda-6 Expression in Non-small-cell Lung Cancer: Relationship to Survival
Caputi, M., Esposito, V., Baldi, A., Luca, A. D., Dean, C., Signoriello, G., Baldi, F., & Giordano, A. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.2.2937m · Cited by 44
Differential regulation of p27 and cyclin D1 by TGF-β and EGF in C3H 10T1/2 mouse fibroblasts
Ravitz, M. J., Yan, S., Dolce, C., Kinniburgh, A. J., & Wenner, C. E. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199609)168:3<510::aid-jcp3>3.0.co;2-s · Cited by 40
Chromosome instability and deregulated proliferation: an unavoidable duo
Coschi, C. H., & Dick, F. A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0910-4 · Cited by 41
Mohapatra, P., Satapathy, S. R., Das, D., Siddharth, S., Choudhuri, T., & Kundu, C. N. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.01.011 · Cited by 40
G1 and S-Phase Checkpoints, Chromosome Instability, and Cancer
Nojima, H. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:003 · Cited by 48
Targeting senescence pathways to reverse drug resistance in cancer
Rebbaa, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.011 · Cited by 42
Metadata
- Authors
- Waga, S., Hannon, G. J., Beach, D., & Stillman, B.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1994-06
- Volume
- 369
- Issue
- 6481
- Pages
- 574-578
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003282728
- Cited by
- 1,655
- References
- 31
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 21 · 2023: 22 · 2022: 25 · 2021: 17 · 2020: 25 · 2019: 31 · 2018: 23 · 2017: 25 · 2016: 23 · 2015: 25 · 2014: 27 · 2013: 23 · 2012: 49
- FWCI
- 55.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p21, cyclin-dependent kinases, PCNA, proliferating cell nuclear antigen, DNA replication, DNA polymerase delta, p53, cell cycle regulation, DNA repair, protein-protein interaction, tumor suppression
- MeSH terms
- Cell Division, Cell Line, DNA Polymerase III, DNA-Directed DNA Polymerase, DNA Replication, DNA Topoisomerases, Type I, DNA, Viral, Histidine, Humans, Nuclear Proteins, Recombinant Proteins, Simian virus 40, Cyclins, Proliferating Cell Nuclear Antigen, Protein Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.